H. pylori virulence factors

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 105-120

  Atherton, John C ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CYTOTOXIN;

BACTERIAL VIRULENCE; DNA POLYMORPHISM; GENOTYPE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LEUKOCYTE ACTIVATION; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA;

EID: 0031929493     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011662     Document Type: Review

References (73)

1. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (Suppl 2): 59-70
2. Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997; 40: 701-3
3. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994; 120: 982-6
4. Lee JE, Lowy AM, Thompson WA et al. Association of gastric adenocarcinoma with the HLA class II gene DQB1*0301. Gastroenterology 1996; 111: 426-32
5. Hein HO, Suadicani P, Gyntelberg F. Genetic markers for peptic ulcer - a study of 3387 men aged 54 to 74 years: the Copenhagen male study. Scand J Gastroenterol 1997; 32: 16-21
6. Mendall MA, Goggin PM, Molineaux N et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-7
7. Martin DF, Montgomery E, Dobeck AS, Patrissi GA, Peura DA. Campylobacter pylori, NSAIDs and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268-72
8. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52: 6735-40
9. Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonisation of gnotobiotic piglets by Helicobacter pylori deficient in 2 flagellin genes. Infect Immun 1996; 64: 2445-8
10. Eaton KA, Krakowka S. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun 1994; 62: 3586-7
11. Dhaenens L, Szczebara F, Musson MO. Identification, characterisation and immunogenicity of the lactoferrin binding protein from Helicobacter pylori. Infect Immun 1997; 65: 604-8
12. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylon and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945-50
13. Mai UEH, Perez-Perez GI, Allen JB, Wahl SM, Blaser MJ, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1993; 175: 517-25
14. Mobley HLT, Cortesia MJ, Rosenthal LE, Jones BD, Characterization of urease from Campylobacter pylori. J Clin Microbiol 1988; 26: 831-6
15. Leunk RD, Johnson PT, David BC et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-9
16. Figura N, Guglielmetti P, Rossolini A et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225-6
17. Goosens H, Glupczynski Y, Burette A. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1992; 1: 153-9
18. Rautelin H, Blomberg B, Järnerot G et al. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol 1994; 29: 128-32
19. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-5
20. Atherton JC, Cao P, Peek RM et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7
21. Rautelin H, Sipponen P, Seppala K, Sarna S, Danielsson D, Kosunen TU. Gastric inflammation and neutrophil-activating and cytotoxin-producing Helicobacter pylori strains. Scand J Gastroenterol 1996; 31: 639-42
22. Zhang QB, Nakshabendi IM, Mokhashi MS, Dawodu JB, Gemmel CG, Russel RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996; 38: 841-5
23. Weel JFL, Vand der Hulst RWM, Gerritis Y et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996; 173: 1171-5
24. Fox JG, Correa P, Taylor NS et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992; 87: 1554-60
25. Murakita H, Hirai M, Ito S et al. Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophic gastritis or duodenal ulcer. J Gastroenterol Hepatol 1996; 11: 819-24
26. Cover TL, Blaser MJ. Purification and characterisation of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-5
27. Cover TL, Tummuru MKR, Cao P et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-73
28. Telford JL, Ghiara P, Dell'Orco M et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8
29. Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 1994; 12: 307-19
30. Phadnis SH. Ilver D, Janzon L et al. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori cytotoxic activity. Infect Immun 1994; 62: 1557-65
31. Lupetti P, Heuser JE, Manetti R et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996; 133: 801-7
32. de Bernard M, Papini E, de Filippis V et al. Low pH activates the vacuolating toxin of Helicobacter pylori which becomes acid and pepsin resistant. J Biol Chem 1995; 270: 23937-40
33. Tricottet V, Bruneval P, Vire O. Campylobacter-like organisms and surface epithelium abnormalities in active chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 1986; 10: 113-22
34. Smoot DT, Regan JH, Earlington MH et al. Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells. Gut 1996; 39: 795-9
35. Garner JA, Cover TL. Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infect Immun 1996; 64: 4192-203
36. Papini E, de Bernard M, Milia E et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 1994; 91: 9720-4
37. Papini E, Satin B, Bucci C et al. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J 1997; 16: 15-24
38. Cover TL, Vaughn SG, Cao P et al. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis 1992; 166: 1073-8
39. Ghiara P, Marchetti M, Blaser MJ et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun 1995; 63: 4154-60
40. Cover TL, Cao P, Murthy UK et al. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992; 90: 913-8
41. Atherton JC, Peek RM, Tham KT et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-9
42. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serological response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-10
43. Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332-5
44. Xiang Z, Bugnoli M, Ponzetto A et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993; 12: 739-45
45. + Helicobacter pylori strains. J Clin Microbiol 1995; 33: 1496-500
46. Ching CK, Wong BCY, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91: 949-53
47. Graham DY, Genta RM, Graham DP, Crabtree JE. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer - lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 1996; 49: 829-32
48. Blaser MJ, Pérez-Pérez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5
49. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk factor for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301
50. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5
51. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high molecular mass major antigen of Helicobacter pylori: evidence for linkage to cytotoxin production. Infect Immun 1993; 61: 1799-809
52. Karita M, Tummuru MKR, Wirth HP, Blaser MJ. Effect of growth phase and acid shock on Helicobacter pylori cagA expression. Infect Immun 1996; 64: 4501-7
53. + Helicobacter pylori strains. Lab Invest 1995; 73: 760-70
54. Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994; 62: 2609-13
55. Censini S, Lange C, Xiang ZY et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53
56. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homolog of the Bordatella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995; 18: 867-76
57. Covacci A, Falkow S, Berg DE, Rappuoli R. Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol 1997; 5: 205-8
58. Hacker J, Blum-Oehler G, Muhldorfer I Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997; 23: 1089-97
59. Evans DJ, Evans DG, Takemura T et al. Characterization of a Helicobacter pylori neutrophil activating protein. Infect Immun 1995; 63: 2213-20
60. Evans DJ, Evans DG, Lampert HC, Nakano H. Identification of four new prokaryotic bacterioferritins, from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequences. Gene 1995; 153: 123-7
61. Kuipers EJ, Israel DA, Blaser MJ. DNA transfer in Helicobacter pylori. Gut 1996; 39 (Suppl 2): A10
62. Go MR, Kapur V, Graham DY et al. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol 1996; 178: 3934-8
63. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9
64. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997; 349: 1020-2
65. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
66. Cover TL, Cao P, Lind CD et al. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12
67. Perez-Perez GI, Tham KT, Peek RM, Atherton JC, Blaser MJ, Cover TL. Serologic responses to type m1 and m2 H. pylori VacA antigens. Gut 1997; 41: A110
68. Stephens JC, Folwell AM, Swann RA et al. H. pylori cagA status, vacA genotypes and ulcer disease. Gut 1996; 39: W7
69. Queiroz DMM, Mendes EN, Rocha GA et al. Gastric carcinoma (GC) strains of H.pylori present vacA sequence that allows to differentiate them from duodenal ulcer (DU) and chronic gastritis (CG) strains. Gut 1996; 39: A66
70. Atherton JC, Karita M, Gonzalez-Valencia G et al. Diversity in vacA mid-region sequence but not in signal sequence type among Helicobacter pylori strains from Japan, China, Thailand and Peru. Gut 1996; 39: A73
71. Hansson LE, Nyrén O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9
72. Marchetti M, Aricò B, Burroni D et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8
73. Atherton JC, Cover TL, Blaser MJ. Helicobacter pylori: thoughts on the implications of infection and on vaccine development. In: NIH (Eds) The Jordan Report: Accelerated Development of Vaccines 1995.Bethesda, MD: National Institutes of Health, 1995; 60-2